Proceedings Volume 10479 is from: Logo
27 January - 1 February 2018
San Francisco, California, United States
Front Matter: Volume 10479
Proc. SPIE 10479, Front Matter: Volume 10479, 1047901 (20 April 2018); doi: 10.1117/12.2315737
Photonic Diagnosis I: Raman spectroscopy
Proc. SPIE 10479, High throughput Raman spectroscopy for host-pathogen interactions (Conference Presentation), 1047903 (14 March 2018); doi: 10.1117/12.2290047
Proc. SPIE 10479, Rapid bacterial identification based on surface-enhanced Raman scattering and machine learning (Conference Presentation) (Withdrawal Notice), 1047904 (10 April 2018); doi: 10.1117/12.2291601
Photonic Diagnosis II
Proc. SPIE 10479, Unraveling bacterial networks and their antimicrobial susceptibility on silicon microarchitectures using intrinsic phase-shift spectroscopy, 1047907 (8 February 2018); doi: 10.1117/12.2287655
Proc. SPIE 10479, A digital microarray for transcriptional biomarkers of antibiotic resistance utilizing plasmonic nanorods and interferometric imaging (Conference Presentation), 1047908 (14 March 2018); doi: 10.1117/12.2290068
Proc. SPIE 10479, Elastic light scattering for clinical pathogens identification: application to early screening of Staphylococcus aureus on specific medium, 1047909 (8 February 2018); doi: 10.1117/12.2287698
Photonic Diagnosis III
Proc. SPIE 10479, Usage of light for enhanced sensing and treating of inflammations and infections (Conference Presentation), 104790B (14 March 2018); doi: 10.1117/12.2287083
Proc. SPIE 10479, Noninvasive monitoring local variations of fever and edema on human: potential for point-of-care inflammation assessment, 104790D (8 February 2018); doi: 10.1117/12.2288659
Proc. SPIE 10479, Engineered bioluminescent influenza viruses shed light on defense against influenza virus infection (Conference Presentation), 104790E (14 March 2018); doi: 10.1117/12.2291867
Photonic Diagnosis IV
Proc. SPIE 10479, Imaging and navigation of remote controlled nanostructured carriers for theranostics (Conference Presentation), 104790F (14 March 2018); doi: 10.1117/12.2291963
Antimicrobial Blue Light I
Proc. SPIE 10479, Antimicrobial blue light: a drug-free approach for inactivating pathogenic microbes, 104790J (8 February 2018); doi: 10.1117/12.2283019
Proc. SPIE 10479, Blue light enhances the antimicrobial activity of honey against Pseudomonas aeruginosa, 104790K (8 February 2018); doi: 10.1117/12.2291644
Proc. SPIE 10479, Microbial photoinactivation by 470 nm radiation: an investigation into the underlying photobiological mechanism , 104790L (8 February 2018); doi: 10.1117/12.2289110
Proc. SPIE 10479, In vitro results of flexible light-emitting antimicrobial bandage designed for prevention of surgical site infections , 104790M (8 February 2018); doi: 10.1117/12.2290743
Proc. SPIE 10479, Antimicrobial blue light inactivation of biofilms formed by clinical isolates of multidrug-resistant microorganisms, 104790N (8 February 2018); doi: 10.1117/12.2288520
Proc. SPIE 10479, Antimicrobial blue light inactivation of Neisseria gonorrhoeae, 104790O (8 February 2018); doi: 10.1117/12.2291545
Antimicrobial Blue Light II
Proc. SPIE 10479, Staphyloxanthin photobleaching sensitizes methicillin-resistant Staphylococcus aureus to reactive oxygen species attack, 104790R (8 February 2018); doi: 10.1117/12.2291248
Proc. SPIE 10479, Photodynamic activity of natural anthraquinones on fibroblasts, 104790S (8 February 2018); doi: 10.1117/12.2290666
Antimicrobial Photodynamic Inactivation/Therapy I
Proc. SPIE 10479, Potentiation of antimicrobial photodynamic inactivation by potassium iodide and other inorganic salts (Conference Presentation), 104790T (14 March 2018); doi: 10.1117/12.2287547
Proc. SPIE 10479, Effect and mechanisms of photodynamic therapy in treating chronic skin ulcers infected with Pseudomonas aeruginosa (Conference Presentation), 104790U (14 March 2018); doi: 10.1117/12.2289032
Proc. SPIE 10479, Photodynamic inactivation (PDI) over cariogenic biofilm using photosensitizers based on curcumin (Conference Presentation), 104790W (14 March 2018); doi: 10.1117/12.2289775
Proc. SPIE 10479, Impact of rose bengal and riboflavin photodynamic antimicrobial therapy (PDAT) on virulence factors of methicillin-resistant staphylococcus aureus (MRSA) ocular species (Conference Presentation), 104790X (14 March 2018); doi: 10.1117/12.2292567
Antimicrobial Photodynamic Inactivation/Therapy II
Proc. SPIE 10479, Decacationic [70]fullerenyl-light harvesting chromophore conjugates for efficient photokilling of infectious bacteria (Conference Presentation), 104790Y (14 March 2018); doi: 10.1117/12.2289070
Proc. SPIE 10479, A quaternary ammonium modified coumarin derivative for antimicrobial photodynamic therapy, 104790Z (8 February 2018); doi: 10.1117/12.2287086
Proc. SPIE 10479, Potassium iodide potentiates antimicrobial photodynamic inactivation mediated by Rose Bengal: in vitro and in vivo studies, 1047911 (8 February 2018); doi: 10.1117/12.2288898
Antimicrobial Photodynamic Inactivation/Therapy III
Proc. SPIE 10479, Progress toward development of photodynamic vaccination against infectious/malignant diseases and photodynamic mosquitocides, 1047912 (8 February 2018); doi: 10.1117/12.2281437
Proc. SPIE 10479, A comparative analysis of aPDI effect of phenothiazinium dyes in presence of inorganic salt as potentiator, 1047914 (8 February 2018); doi: 10.1117/12.2290699
Proc. SPIE 10479, Antimicrobial photodynamic inactivation mediated by a class of dual-action light-activated antibiotics: tetracyclines is potentiated by potassium iodide (Conference Presentation), 1047915 (14 March 2018); doi: 10.1117/12.2287566
Antimicrobial Photodynamic Inactivation/Therapy IV
Proc. SPIE 10479, Biodistribution and toxicity assessment of photoactivatable antibody-conjugated, antibiotic loaded gold nanocages for the treatment of bacterial infections (Conference Presentation), 1047916 (14 March 2018); doi: 10.1117/12.2288471
Proc. SPIE 10479, Photodynamic therapy to destroy pneumonia associated microorganisms using external irradiation source, 1047917 (8 February 2018); doi: 10.1117/12.2290764
Proc. SPIE 10479, Potentiation by potassium iodide using TPPS4 for antimicrobial photodynamic inactivation, 1047918 (8 March 2018); doi: 10.1117/12.2285246
Proc. SPIE 10479, Antimicrobial photodynamic therapy proved not to induce bacterial resistance (Conference Presentation), 1047919 (14 March 2018); doi: 10.1117/12.2287268
Ultraviolet and Infrared Irradiation Treatment
Proc. SPIE 10479, Healthcare acquired infection (HAIs): a deadly problem that is preventable: UV can help, what’s holding it back?, 104791A (8 February 2018); doi: 10.1117/12.2288584
Proc. SPIE 10479, Identification of barriers and research opportunities to improve the effective and efficient application of adjunct UVC surface disinfection in healthcare, 104791B (8 February 2018); doi: 10.1117/12.2291091
Proc. SPIE 10479, Insights into the working mechanism of water filtered infrared A (wIRA) irradiation on Chlamydia trachomatis serovar E , 104791C (8 February 2018); doi: 10.1117/12.2287834
Proc. SPIE 10479, Far-UVC light applications: sterilization of MRSA on a surface and inactivation of aerosolized influenza virus, 104791D (8 February 2018); doi: 10.1117/12.2309424
Poster Session
Proc. SPIE 10479, Efficacy of antimicrobial 405 nm blue-light for inactivation of airborne bacteria, 104791G (8 February 2018); doi: 10.1117/12.2289987
Proc. SPIE 10479, Effectiveness of photobiomodulation therapy and aerobic exercise training on articular cartilage in an experimental model of osteoarthritis in rats , 104791K (8 February 2018); doi: 10.1117/12.2291227
Proc. SPIE 10479, Effects of the photodynamic therapy on microbial reduction of diabetic ulcers in humans, 104791L (8 February 2018); doi: 10.1117/12.2291344
Back to Top